Sandra Pollitt

504 total citations
10 papers, 413 citations indexed

About

Sandra Pollitt is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sandra Pollitt has authored 10 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sandra Pollitt's work include Drug Transport and Resistance Mechanisms (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Veterinary Equine Medical Research (2 papers). Sandra Pollitt is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Veterinary Equine Medical Research (2 papers). Sandra Pollitt collaborates with scholars based in Australia and United Kingdom. Sandra Pollitt's co-authors include M.A. Pass, C. C. Pollitt, C. C. Pollitt, Ian A. Shiels, Lavinia M. Proctor, Trent M. Woodruff, Peter N. Monk, James W. Crane, Kathryn M. Buller and Kurt J. De Vos and has published in prestigious journals such as The FASEB Journal, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmaceutical Sciences.

In The Last Decade

Sandra Pollitt

10 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Pollitt Australia 7 164 133 87 72 55 10 413
Judith Field Australia 14 228 1.4× 301 2.3× 191 2.2× 138 1.9× 35 0.6× 26 802
Zofia M. Lisowski United Kingdom 13 46 0.3× 206 1.5× 36 0.4× 146 2.0× 67 1.2× 17 505
Julian Oliver United States 12 43 0.3× 46 0.3× 20 0.2× 35 0.5× 9 0.2× 29 284
G. G. Gum United States 16 107 0.7× 22 0.2× 15 0.2× 143 2.0× 12 0.2× 32 729
Leipold Hw 14 46 0.3× 9 0.1× 44 0.5× 82 1.1× 62 1.1× 48 470
Jeanette Hanson Sweden 16 49 0.3× 41 0.3× 28 0.3× 242 3.4× 6 0.1× 38 853
J. Campos Portugal 10 105 0.6× 94 0.7× 135 1.6× 38 0.5× 13 0.2× 15 504
C. Zaragoza Spain 13 31 0.2× 21 0.2× 21 0.2× 133 1.8× 8 0.1× 25 558
Kate L. Tsai United States 14 37 0.2× 53 0.4× 5 0.1× 272 3.8× 20 0.4× 26 566
Andria Doty United States 10 19 0.1× 150 1.1× 37 0.4× 82 1.1× 18 0.3× 20 339

Countries citing papers authored by Sandra Pollitt

Since Specialization
Citations

This map shows the geographic impact of Sandra Pollitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Pollitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Pollitt more than expected).

Fields of papers citing papers by Sandra Pollitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Pollitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Pollitt. The network helps show where Sandra Pollitt may publish in the future.

Co-authorship network of co-authors of Sandra Pollitt

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Pollitt. A scholar is included among the top collaborators of Sandra Pollitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Pollitt. Sandra Pollitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Morgan, Michael, Andrew C. Bulmer, Trent M. Woodruff, et al.. (2008). Pharmacokinetics of a C5a receptor antagonist in the rat after different sites of enteral administration. European Journal of Pharmaceutical Sciences. 33(4-5). 390–398. 18 indexed citations
2.
Woodruff, Trent M., James W. Crane, Lavinia M. Proctor, et al.. (2006). Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. The FASEB Journal. 20(9). 1407–1417. 131 indexed citations
3.
Woodruff, Trent M., James W. Crane, Kathryn M. Buller, et al.. (2006). Complement C5a receptor antagonists protect against striatal degeneration in a rat model of Huntington's disease. 20. 1407–1417. 1 indexed citations
4.
Woodruff, Trent M., Sandra Pollitt, Lavinia M. Proctor, et al.. (2005). Increased Potency of a Novel Complement Factor 5a Receptor Antagonist in a Rat Model of Inflammatory Bowel Disease. Journal of Pharmacology and Experimental Therapeutics. 314(2). 811–817. 65 indexed citations
5.
Pollitt, Sandra, et al.. (1999). Analysis of the amino acid indospicine in biological samples by high performance liquid chromatography. Natural Toxins. 7(6). 233–240. 13 indexed citations
6.
Pollitt, Sandra, et al.. (1999). Analysis of the amino acid indospicine in biological samples by high performance liquid chromatography. Natural Toxins. 7(6). 233–240. 1 indexed citations
7.
Pass, M.A., Sandra Pollitt, & C. C. Pollitt. (1998). Decreased glucose metabolism causes separation of hoof lamellae in vitro : a trigger for laminitis?. Equine Veterinary Journal. 30(S26). 133–138. 95 indexed citations
8.
Pollitt, C. C., M.A. Pass, & Sandra Pollitt. (1998). Batimastat (BB‐94) inhibits matrix metalloproteinases of equine laminitis. Equine Veterinary Journal. 30(S26). 119–124. 76 indexed citations
9.
10.
Pass, M.A., Miriam Goosem, & Sandra Pollitt. (1985). A relationship between hepatic metabolism of reduced lantadene a and its toxicity in rats and sheep. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 82(2). 457–461. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith Field Breakdown of academic impact, for papers by Zofia M. Lisowski Breakdown of academic impact, for papers by Julian Oliver Breakdown of academic impact, for papers by G. G. Gum Breakdown of academic impact, for papers by Leipold Hw Breakdown of academic impact, for papers by Jeanette Hanson Breakdown of academic impact, for papers by J. Campos Breakdown of academic impact, for papers by C. Zaragoza Breakdown of academic impact, for papers by Kate L. Tsai Breakdown of academic impact, for papers by Andria Doty
Rankless by CCL
2026